Company Filing History:
Years Active: 1999-2003
Title: The Innovative Contributions of Simon David Scott
Introduction
Simon David Scott is a notable inventor based in Huntingdon, GB. He has made significant contributions to the field of virology, particularly in the development of vaccines through his innovative research. With a total of 5 patents, Scott's work has had a profound impact on the understanding and manipulation of viral nucleotide sequences.
Latest Patents
Scott's latest patents focus on the identification of various genes associated with the herpes virus of turkeys (HVT), Marek's disease virus (MDV), and infectious laryngotracheitis virus (ILTV). These patents detail non-essential regions that serve as candidates for insertion sites for foreign genes, as well as antigen-encoding regions. The identified regions include the HVT homologue of the HSV gC gene, the thymidine kinase region of MDV or ILTV, and several others. His work allows for the preparation of vaccines that comprise attenuated viruses or viruses carrying heterologous antigen-encoding sequences.
Career Highlights
Throughout his career, Simon David Scott has worked with prominent companies in the biotechnology sector, including Merial Limited and Rhone Merieux S.A. His expertise in virology and vaccine development has positioned him as a key figure in the industry.
Collaborations
Scott has collaborated with notable professionals in his field, including Annette Mary Griffin and Matthew M Binns. These collaborations have further enhanced his research and contributions to vaccine development.
Conclusion
In summary, Simon David Scott's innovative work in virology and vaccine development has led to significant advancements in the field. His patents and collaborations reflect his dedication to improving public health through scientific research.